MTIP AG is a Swiss-based specialist growth and buyout investor founded in 2014 that focuses exclusively on European healthcare technology. See contact routes.
MTIP AG is a Swiss-based specialist growth and buyout investor founded in 2014 that focuses exclusively on European healthcare technology, particularly AI-enabled and software-driven health companies. The firm’s investment thesis targets digitally connected, patient-centric medical technology leaders based primarily in Europe, investing through both majority and minority structures to scale market-leading businesses. MTIP typically considers investments between EUR 10 million and EUR 50 million and engages in both buyout (buy-in) and expansion (development capital) stages. While the firm does not publicly specify lead versus follow behavior, its active ownership approach and deep sector expertise suggest a hands-on, partnership-oriented model with founders and management teams. Notable portfolio companies are not explicitly named in available public sources, though MTIP reports holding more than 15 portfolio companies across its MTIP Fund I and Fund II. A distinctive point of view is MTIP’s integrated business model for MedTech start-ups, which combines financing with professional IP management and targeted business development, as launched by CEO Dr. Ch
Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist comparable investors.
Investors like Mtip AG · Full investor directory · Investor access · Company funding database